Author: <span>Mesothelioma News</span>

Novocure Announces Agenda for Research and Development Day on Dec. 12, 2016

Novocure announced today the agenda for the company’s research and development day for analysts and investors, which will begin at 1 p.m. EST on Monday, Dec. 12, 2016, in New York City. The event will feature four speakers from Novocure and three external medical experts who will provide analyses from completed clinical trials, including the full, 695-patient trial cohort from the EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma , new data from the PANOVA phase 2 pilot trial in advanced pancreatic cancer, new data from the INNOVATE phase 2 pilot trial in recurrent ovarian cancer, and interim data from the STELLAR phase 2 pilot trial in mesothelioma.

North Vancouver may join nationwide call on federal government to ban asbestos

The Canadian Labour Congress is urging the federal government to ban the import and use of asbestos in the country, and the city of North Vancouver may soon follow suit. During a news conference Wednesday in North Vancouver alongside the Canadian Labour Congress , the city’s mayor Darrell Mussatto said city council will hold a vote on Dec. 12 to decide on whether to join the nationwide movement.

Boehringer Ingelheim Release: Clinically Meaningful Data For Oral…

The data, presented at the 17th IASLC World Conference on Lung Cancer in , showed nintedanib plus pemetrexed/cisplatin demonstrated a meaningful clinical benefit compared to placebo plus pemetrexed/cisplatin, with a significantly improved PFS . Prelimi…

Summary of research presented at the IASLC 17th World Conference on Lung Cancer

December 7, 2016–Today’s press briefing at the IASLC 17th World Conference on Lung Cancer focused on clinical trials that advance the progress made in lung cancer treatment through immunotherapy and better diagnostics. Abstracts and full versions of news releases for each topic covered are available through links in this summary, or through IASLC media representative Chris Martin at cmartin@davidjamesgroup.com .

Merck & Co. Release: Updated KEYTRUDA (Pembrolizumab) Data In Small…

Merck , known as MSD outside the United States and Canada, today announced that updated findings from the phase 1b KEYNOTE-028 study investigating the use of KEYTRUDAA , the company’s anti-PD-1 therapy, in previously treated patients with advanced small cell lung cancer and malignant pleural mesothelioma, showed clinical activity and durable responses in some patients. These data were featured in oral presentations at the 17th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer.

BRIEF-Merck presents updated Keytruda data in small cell lung cancer and mesothelioma

WASHINGTON, Dec 6 The U.S. Supreme Court on Tuesday sided with Samsung in its big-money smartphone patent fight with Apple, throwing out an appeals court ruling that said the South Korean company had to pay a $399 million penalty to its American rival …

BRIEF-Merck presents updated Keytruda data in small cell lung cancer and mesothelioma

WASHINGTON, Dec 6 The U.S. Supreme Court on Tuesday sided with Samsung in its big-money smartphone patent fight with Apple, throwing out an appeals court ruling that said the South Korean company had to pay a $399 million penalty to its American rival …

Devon teacher died from asbestos exposure in Buckinghamshire…

Teacher, 68, died from asbestos exposure after builders removed the deadly fibres from classrooms while she taught lessons during her 30-year career The grandmother was diagnosed with malignant mesothelioma, which can lie dormant for decades, in 2014 and died in June this year. During the inquest, held at Exeter’s County Hall, the court heard that Sue had written a statement saying she recalled construction work being undertaken at another school and asbestos being removed by builders in the classrooms during lessons.

Advocacy and community health care models complement research and clinical care

Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the first day of the IASLC 17th …

Asbestos Still Lurks in Many Commercial and Residential Properties in Puerto Rico

Asbestos was used for decades in many building products found in Puerto Rico and across the Caribbean. It is a naturally occurring mineral fiber that when added to building products, offers desirable attributes such as increased strength, corrosion res…